2.27
price up icon0.44%   0.01
after-market After Hours: 2.30 0.03 +1.32%
loading

Acumen Pharmaceuticals Inc Stock (ABOS) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
3.85%
17.77
18.49 16.04 13.48 13.13
Interest Income/Expense
1.00
- - - -
Operating Income/Loss
3.85%
-17.77
-18.49 -16.04 -13.48 -13.13
Nonoperating Income/Loss
45.85%
2.901
1.989 3.082 1.868 1.828
Income/Loss From Continuing Operations Before Tax
9.84%
-14.87
-16.50 -12.96 -11.61 -11.31
Income/Loss From Continuing Operations After Tax
9.84%
-14.87
-16.50 -12.96 -11.61 -11.31
Net Income/Loss
9.84%
-14.87
-16.50 -12.96 -11.61 -11.31
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,808%
59.81
3.1344 54.23 41.03 41.03
Diluted Average Shares
1,808%
59.81
3.1344 54.23 41.03 41.03
Basic Earnings Per Share
13.79%
-0.25
-0.29 -0.24 -0.28 -0.28
Diluted Earnings Per Share
13.79%
-0.25
-0.29 -0.24 -0.28 -0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.50
price up icon 1.61%
$74.59
price down icon 1.14%
$370.49
price down icon 2.02%
$43.06
price down icon 0.76%
$215.00
price up icon 4.29%
$118.39
price down icon 1.93%
Cap:     |  Volume (24h):